Retroviral-mediated transfer of the iduronate-2-sulfatase gene into lymphocytes for treatment of mild hunter syndrome (mucopolysaccharidosis type II)

Human Gene Therapy

Volumn 7, Issue 4, 1996, Pages 537-549

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

IDURONATE 2 SULFATASE;

ARTICLE; CASE REPORT; CLINICAL PROTOCOL; CLINICAL TRIAL; GENE THERAPY; HUMAN; HUMAN CELL; HUNTER SYNDROME; LYMPHOCYTE; RETROVIRUS;

ADULT; CLINICAL PROTOCOLS; FEASIBILITY STUDIES; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HUMANS; IDURONATE SULFATASE; MUCOPOLYSACCHARIDOSIS II; RETROVIRIDAE; T-LYMPHOCYTES;

UNIDENTIFIED RETROVIRUS;

EID: 0029965750     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.1996.7.4-537     Document Type: Article

References (65)

1. Neufeld, E.F. & Muenzer, J. (1989). The Metabolic Basis of Inherited Diseases (eds. Scriver, C.R., Beaudet, A.L., Sly, W.S. & Valle, D.) pp. 1565-1587 (McGraw-Hill, New York).
2. Whitley, C.B. (1992). In McKusick's Heritable Diseases of Connective Tissue (eds. Beighton, P.) pp. 367-499 (Mosby, St. Louis).
3. Hopwood, J.J. & Morris, C.P. (1990). The mucopolysaccharidoses. Diagnosis, molecular genetics and treatment, Mol Biol Med 7, 381-404.
4. Young, I.D., Harper, P.S., Newcombe, R.G. & Archer, I.M. (1982). A clinical and genetic study of Hunter's syndrome. 2. Differences between the mild and severe forms, J Med Genet 19, 408-411.
5. Young, I.D. & Harper, P.S. (1982). Mild form of Hunter's syndrome clinical delineation based on 31 cases, Arch Dis Child 57, 828-836.
6. Wilson, P.J., Morris, C.P., Anson, D.S., Occhiodoro, T., Bielicki, J., Clements, P.R. & Hopwood, J.J. (1990). Hunter syndrome isolation of an iduronate-2-sulfatase cDNA clone and analysis of patient DNA, Proc Natl Acad Sci USA 87, 8531-8535.
7. Wilson, P.J., Suthers, G.K., Callen, D.F., Baker, E., Nelson, P.V., Cooper, A., Wraith, J.E., Sutherland, G.R., Morris, C.P. & Hopwood, J.J. (1991). Frequent deletions at Xq28 indicate genetic heterogeneity in Hunter syndrome, Hum Genet 86, 505-508.
8. Palmieri, G., Capra, V., Romano, G., D'Urso, M., Johnson, S., Schlessinger, D., Morris, P., Hopwood, J., Di Natale, P., Gatti, R. & Ballabio, A. (1992). The iduronate sulfatase gene isolation of a 1.2-Mb YAC contig spanning the entire gene and identification of heterogeneous deletions in patients with Hunter syndrome, Genomics 12, 52-57.
9. Wehnert, M., Hopwood, J.J., Schroder, W. & Herrmann, F.H. (1992). Structural gene aberrations in mucopolysaccharidosis II (Hunter), Human Genetics 89, 430-432.
10. Flomen, R.H., Green, P.M., Bentley, D.R., Giannelli, F. & Green, E.P. (1992). Detection of point mutations and a gross deletion in six Hunter syndrome patients, Genomics 13, 543-550.
11. Crotty, P.L. & Whitley, C.B. (1992). Assessment of iduronate-2-sulfatase mRNA expression in Hunter syndrome (mucopolysaccharidosis type II), Hum Genet 90, 285-288.
12. Jonsson, J.J., Aronovich, E.L., Braun, S.E., & Whitley CB (1995). Molecular diagnosis of mucopolysaccharidosis type II (Hunter syndrome) by automated sequencing and computer-assisted analysis toward mutation mapping of the iduronate-2-sulfatase gene, Am J Hum Genet 56, 597-607.
13. Crotty, P.L., Braun, S.E., Anderson, R.A. & Whitley, C.B. (1992). Mutation R468W of the iduronate-2-sulfatase gene in mild Hunter syndrome (mucopolysaccharidosis type II) confirmed by in vitro mutagenesis and expression, Hum Mol Genet 1, 755-757.
14. Sukegawa, K., Tomatsu, S., Tamai, K., Ikeda, M., Sasaki, T., Masue, M., Fukuda, S., Yamada, Y. & Orii, T. (1992). Intermediate form of mucopolysaccharidosis type II (Hunter disease) a C1327 to T substitution in the iduronate sulfatase gene, Biochem Biophys Res Commun 183, 809-813.
15. Bunge, S., Steglich, C., Beck, M., Rosendranz, W., Schwinger, E., Hopwood, J.J. & Gal, A. (1992). Mutation analysis of the iduronate-2-sulfatase gene in patients with mucopolysaccharidosis type II (Hunter syndrome), Hum Mol Genet 1, 335-339.
16. Bach, G., Moskowitz, S.M., Shimon-Schiff, E.B., Zlotogora, J., Tieu, P.T. & Neufeld, E.F. (1993). Mutation analysis of Hurler and Hunter syndrome in Israel unusual distribution in Jewish and Arab populations (Essen, Germany).
17. Sukegawa, K., Yamada, Y., Tomatsu, S., Fukuda, S. & Orii, T. (1993). Molecular analysis of mucopolysaccharidosis type II (Hunter disease) (Essen, Germany).
18. Goldenfum, S., Malcolm, S., Young, E. & Winchester, B. (1993). Mutation analysis in patients with Hunter's disease (Essen, Germany).
19. Hermann, F.H., Schroder, W., Wolff, K., Wehnert, M. & Seidlitz, G. (1993) Structural gene aberrations in MPS II (Hunter syndrome) (Essen, Germany).
20. Hobbs, J.R. (1981).Bone marrow transplantation for inborn errors, Lancet 2, 735-739.
21. Hobbs, J.R., Hugh-Jones, K., Barrett, A.J., Byrom, N., Chambers, D., Henry, K., James, D.C., Lucas, C.F., Rogers, T.R., Benson, P.F., Tansley, L.R., Patrick, A.D., Mossman, J. & Young, E.P. (1981). Reversal of clinical features of Hurler's disease and biochemical improvement after treatment by bone-marrow transplantation, Lancet 2, 709-712.
22. Whitley, C.B., Ramsay, N.K.C., Kersey, J.H. & Krivit, W. (1986). Bone marrow transplantation for Hurler syndrome assessment of metabolic correction, Birth Defects 22, 7-24.
23. Gasper, P.W., Thrall, M.A., Wenger, D.A., Macy, D.W., Ham, L., Dornsife, R.E., McBiles, K., Quackenbush, S.L., Kesel, M.L., Gillette, E.L. et al. (1984). Correction of feline arylsulphatase B deficiency (mucopolysaccharidosis VI) by bone marrow transplantation, Nature 312, 467-469.
24. Shull, R.M., Hastings, N.E., Selcer, R.R., Jones, J.B., Smith, J.R., Cullen, W.C. & Constantopoulos, G. (1987). Bone marrow transplantation in canine mucopolysaccharidosis I. Effects within the central nervous system, J Clin Invest 79, 435-443.
25. Shull, R.M., Breider, M.A. & Constantopoulos, G.C. (1988). Long-term neurological effects of bone marrow transplantation in a canine lysosomal storage disease, Pediatr Res 24, 347-352.
26. Shull, R.M. & Walker, M.A. (1988). Radiographic findings in a canine model of mucopolysaccharidosis I. Changes associated with bone marrow transplantation. Invest Radiol 23, 124-130.
27. Birkenmeier, E.H., Barker, J.E., Vogler, C.A., Kyle, J.W., Sly, W.S., Gwynn, B., Levy, B. & Pegors, C. (1991). Increased life span and correction of metabolic defects in murine mucopolysaccharidosis type VII after syngeneic bone marrow transplantation, Blood 78, 3081-3092.
28. Krivit, W., Whitley, C.B., Chang, P.-N., Shapiro, E., Belani, K.G., Snover, D., Summers, C.G. & Blazar, B.R. (1990). In Bone Marrow Transplantation in Children (eds. Johnson, F.L. & Pochedly, C.) pp. 261-287 (Raven Press, Ltd., New York).
29. Whitley, C.B., Belani, K.G., Chang, P.-N., Summers, C.G., Blazar, B.R., Tsai, M.Y., Latchaw, R.E., Ramsay, N.K.C. & Kersey, J.H. (1993). Long-term outcome of Hurler syndrome following bone marrow transplantation, Am J Med Genet 46, 209-218.
30. Resnick, J.M., Krivit, W., Snover, D.C., Kersey, J.H., Ramsay, N.K., Blazar, B.R. & Whitley, C.B. (1992). Pathology of the liver in mucopolysaccharidosis light and electron microscopic assessment before and after bone marrow transplantation, Bone Marrow Transplant 10, 273-280.
31. Malone, B.N., Whitley, C.B., Duvall, A.J., Belani, K., Sibley, R.K., Ramsay, N.K., Kersey, J.H., Krivit, W. & Berlinger, N.T. (1988). Resolution of obstructive sleep apnea in Hurler syndrome after bone marrow transplantation, Int J Pediatr Otorhinolaryngol 15, 23-31.
32. Summers, C.G., Purple, R.L., Krivit, W., Pineda, R., Copland, G.T., Ramsay, N.K., Kersey, J.H. & Whitley, C.B. (1989). Ocular changes in the mucopolysaccharidoses after bone marrow transplantation. A preliminary report, Ophthalmology 96, 977-984.
33. Whitley, C.B., Krivit, W., Ramsay, N.K.C., Kersey, J.H., Chang, P.N., Latchaw, R.E., Blazar, B.R., Scott, H.S., Nelson, P.V., Morris, C.P. & Hopwood, J.J. (1993). Mutation analysis and clinical outcome of patients with Hurler syndrome (mucopolysaccharidosis type I-H) undergoing bone marrow transplantation, Am Soc Hum Genet, 53:101, 1993.
34. Fratantoni, J.C., Hall, C.W. & Neufeld, E.F. (1968). Hurler and Hunter syndromes mutual correction of the defect in cultured fibroblasts, Science 162, 699-706.
35. Hickman, S. & Neufeld, E.F. (1972). A hypothesis for I-cell disease defective hydrolases that do not enter lysosomes, Biochem Biophys Res Commun 49, 992-999.
36. Schweitzer, L.B. & Desnick, R.J. (1983). Inherited metabolic diseases advances in delineation, diagnosis, and treatment, Birth Defects 19, 39-71.
37. Di Ferrante, N., Nichols, B.I., Donnelly, P.V., Neri G., Hrgovcic, R & Berglund R.K. (1971). Induced degradation of glycosaminoglycans in Hurler's and Hunter's syndromes by plasma infusion, Proc Natl Acad Sci USA 68, 303-307.
38. Knudson, A.G., Di Ferrante, N. & Curtis, J.E. (1971). The effect of leukocyte transfusion in a child with type II mucopolysaccharidosis, Proc Natl Acad Sci USA 68, 1738-1741.
39. Adinolfi, M. & Brown, S. (1984). Strategies for the correction of enzymatic deficiencies in patients with mucopolysaccharidoses, Dev Med Child Neurol 26, 404-408.
40. Muenzer, J., Neufeld, E.F., Constantopoulos, G., Caruso, R.C., Kaiser, K.M., Pikus, A., Danoff, J., Berry, R.R., McDonald, H.D. & Thompson, J.N. (1992). Attempted enzyme replacement using human amnion membrane implantations in mucopolysaccharidoses, J Inherit Metab Dis 15, 25-37.
41. Parkman, R. (1986). The application of bone marrow transplantation to the treatment of genetic diseases, Science 232, 1373-1378.
42. Hammer, R.E., Palmiter, R.D. & Brinster, R.L. (1984). Partial correction of murine hereditary growth disorder by germ-line incorporation of a new gene, Nature 311, 65-67.
43. Mason, A.J., Pitts, S.L., Nikolics, K., Szonyi, E., Wilcox, J.N., Seeburg, P.H. & Stewart, T.A. (1986). The hypogonadal mouse reproductive functions restored by gene therapy, Science 234, 1372-1378.
44. Costantini, F., Chada, K. & Magram, J. (1986). Correction of murine beta-thalassemia by gene transfer into the germ line, Science 233, 1192-1194.
45. Readhead, C. & Muggleton, H.A. (1991). The shiverer mouse mutation shi/shi rescue and preimplantation detection, Hum Reprod 6, 93-100.
46. Kyle, J.W., Birkenmeier, E.H., Gwynn, B., Vogler, C., Hoppe, P.C., Hoffmann, J.W. & Sly, W.S. (1990). Correction of murine mucopolysaccharidosis VII by a human beta-glucuronidase transgene, Proc Natl Acad Sci USA 87, 3914-3918.
47. Chowdhury, J.R., Grossman, M., Gupta, S., Chowdhury, N.R., Baker, J.J. & Wilson, J.M. (1991). Long-term improvement of hypercholesterolemia after ex vivo gene therapy in LDLR-deficient rabbits, Science 254, 1802-1805.
48. Hyde, S.C., Gill, D.R., Higgins, C.F. & Trezise, A.E.O. (1993). Correction of ion transport defect in cystic fibrosis transgenic mice by gene therapy, Nature 362, 250-255.
49. Wolfe, J.H., Sands, M.S., Barker, J.E., Gwynn, B., Rowe, L.B., Vogler, C.A. & Birkenmeier, E.H. (1992). Reversal of pathology in murine mucopolysaccharidosis type VII by somatic cell gene transfer, Nature 360, 749-753.
50. Warkentin, P.I., Dixon, M.S., Schafer, I., Strandjord, S.E. & Coccia, P.F. (1986). Bone marrow transplantation in Hunter syndrome a preliminary, Birth Defects 22, 31-39.
51. Rosenberg, S.A., Aebersold, P., Cornetta, K., Kasid, A., Morgan, R.A., Moen, R., Karson, E.M., Lotze, M.T., Yang, J.C., Topalian, S.L. & et al. (1990). Gene transfer into humans - immunotherapy of patients with advanced melanoma, using tumor-infiltrating lymphocytes modified by retroviral gene transduction [see comments], N Engl J Med 323, 570-8.
52. Blaese, R.M. (1993). Development of gene therapy for immunodeficiency adenosine deaminase deficiency, Ped Research 33, S49-S55.
53. (1993) human gene marker/therapy patient registry-summary, Hum Gene Ther 4, 399-400.
54. Kasid, A., Morecki, S., Aebersold, P., Cornetta, K., Culver, K., Freeman, S., Director, E., Lotze, M.T., Blaese, R.M., Anderson, W.F. & et al. (1990). Human gene transfer characterization of human tumor-infiltrating lymphocytes as vehicles for retroviral-mediated gene transfer in man, Proc Natl Acad Sci USA 87, 473-477.
55. Anderson, W. (1990). The ADA human gene therapy clinical protocol, Hum Gene Ther 1, 327-362.
56. Culver, K.W., Anderson, W.F. & Blaese, R.M. (1991). Lymphocyte gene therapy, Hum Gene Ther 2, 107-109.
57. Culver, K., Cornetta, K., Morgan, R., Morecki, S., Aebersold, P., Kasid, A., Lotze, M., Rosenberg, S.A., Anderson, W.F. & Blaese, R.M. (1991). Lymphocytes as cellular vehicles for gene therapy in mouse and man, Proc Natl Acad Sci USA 88, 3155-3159.
58. Olsen, I., Abraham, D., Shelton, I., Bou-Gharios, G., Muir, H. & Winchester, B. (1988). Cell contact induces the synthesis of a lysosomal enzyme precursor in lymphocytes and its direct transfer to fibroblasts, Biochim Biophys Acta 968, 312-322.
59. Olsen, I., Hand, C. & Muir, H. (1987). Multiple transfer of lysosomal enzymes from normal lymphocytes to I-cell disease fibroblasts, Cell Biol Int Rep 11, 131-10.
60. W) for low alpha-L-iduronidase enzyme activity vis-a-vis prenatal diagnosis of Hurler syndrome, Am J Med Genet 28, 233-243.
61. Braun, S.E., Aronovich, E.L., Anderson, R., Crotty, P.L., McIvor, R.S. & Whitley, C.B. (1993). Metabolic correction and cross-correction of mucopolysaccharidosis type II (Hunter syndrome) by retroviral-mediated gene transfer and expression of human iduronate-2-sulfatse, Proc Natl Acad Sci USA 90, 11830-11834.
62. Jonsson, J.J., Braun, S.E., Pan, D., Aronovich, E.L., McIvor, R.S. & Whitley, C.B. (1993). In vitro correction of iduronate-2-sulfatase deficiency in Hunter syndrome (mucopolysaccharidosis type II) with four retroviral vectors, Am Soc Hum Genet 53, 409.
63. Braun, S.E., Jonsson, J.J., Aronovich, E.L., McIvor, R.S. & Whitley, C.B. (1993). A model of ex vivo lymphocyte gene therapy for Hunter syndrome, mucopolysaccharidosis type II, Am Soc Hum Genet 53, 1120.
64. Pan, D., Braun, S.E., Jonsson, J.J., Aronovich, E.L., McIvor, R.S. & Whitley, C.B. (1994). Pre-clinical studies of lymphocyte gene therapy for Hunter syndrome (abstract), J Cell Biochem 18A, 244.
65. Pan, D., Shankar, R., Stroncek, D.F., McCullough, J., McIvor, R.S. & Whitley, C.B. (1995). Retrovirus production and transduction of peripheral blood lymphocytes in a closed artificial capillary system an approach to large scale cell manipulation for clinical gene therapy (abstract), J Cell Biochem 21A, 412.